Company · CIK 0001552451 · SIC 2834 — Pharmaceutical Preparations
MyoKardia Inc · MYOK
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 8, 2017 SForm 4 → | Sep 12, 4:05 pm EDT | Kevin P StarrDirector, 10% Owner | 201,250 | $41.01 | $8,252,499 | 7,486,504 | −2.62% | plan? |
| Sep 5, 2017 SForm 4 → | Sep 7, 4:06 pm EDT | Anastasios GianakakosPresident and CEO, Director | 4,300 | $43.02 | $185,004 | 508,163 | −0.84% | plan? |
| Sep 5, 2017 MForm 4 → | Sep 7, 4:06 pm EDT | Anastasios GianakakosPresident and CEO, Director | 4,300 | $1.51 | $6,479 | 512,463 | — | plan? |
| Aug 22, 2017 SForm 4 → | Aug 24, 4:05 pm EDT | Joseph LambingSee Remarks | 5,000 | $45.00 | $225,000 | 99,718 | −4.77% | plan? |
| Aug 15, 2017 SForm 4 → | Aug 16, 4:32 pm EDT | Joseph LambingSee Remarks | 5,000 | $40.00 | $200,000 | 104,718 | −4.56% | plan? |
| Aug 14, 2017 PForm 4 → | Aug 16, 4:33 pm EDT | Wendy L YarnoDirector | 1,408 | $35.50 | $49,984 | 1,408 | — | plan? |
| Aug 14, 2017 PForm 4 → | Aug 16, 7:31 am EDT | Sanofi10% Owner | 350,000 | $35.50 | $12,425,000 | 4,018,899 | +9.54% | plan? |
| Aug 7, 2017 SForm 4 → | Aug 9, 5:16 pm EDT | Joseph LambingSee Remarks | 15,000 | $30.00 | $450,000 | 109,718 | −12.0% | plan? |
| Aug 7, 2017 SForm 4 → | Aug 9, 5:15 pm EDT | Jake BauerSee Remarks | 15,000 | $28.33 | $425,000 | 65,545 | −18.6% | plan? |
| Aug 4, 2017 SForm 4 → | Aug 4, 9:31 pm EDT | Anastasios GianakakosPresident and CEO, Director | 4,300 | $16.62 | $71,465 | 508,163 | −0.84% | plan? |
| Aug 4, 2017 MForm 4 → | Aug 4, 9:31 pm EDT | Anastasios GianakakosPresident and CEO, Director | 4,300 | $1.51 | $6,479 | 512,463 | — | plan? |
| Jul 25, 2017 SForm 4 → | Jul 27, 5:11 pm EDT | Jake BauerSee Remarks | 4,333 | $15.02 | $65,060 | 80,545 | −5.10% | plan? |
| Jul 25, 2017 SForm 4 → | Jul 27, 5:11 pm EDT | Anastasios GianakakosPresident and CEO, Director | 32,988 | $15.00 | $494,902 | 508,163 | −6.10% | plan? |
| Jul 25, 2017 MForm 4 → | Jul 27, 5:11 pm EDT | Anastasios GianakakosPresident and CEO, Director | 31,850 | $1.51 | $48,094 | 541,151 | — | plan? |
| Apr 28, 2017 AForm 4 → | May 16, 1:49 pm EDT | Jake BauerSee Remarks | 978 | $11.09 | $10,848 | 84,878 | — | plan? late |
| Apr 28, 2017 AForm 4 → | May 16, 1:45 pm EDT | Anastasios GianakakosPresident and CEO, Director | 1,259 | $11.09 | $13,965 | 509,301 | — | plan? late |
| Apr 28, 2017 AForm 4 → | May 16, 1:45 pm EDT | Joseph LambingSee Remarks | 1,135 | $11.09 | $12,590 | 124,718 | — | plan? late |
| Mar 30, 2017 JForm 4 → | Apr 3, 4:01 pm EDT | Third Rock Ventures II, L.P. +410% Owner | 850,000 | — | — | 7,687,754 | — | plan? |
| Mar 30, 2017 JForm 4 → | Apr 3, 4:00 pm EDT | Kevin P StarrDirector, 10% Owner | 850,000 | — | — | 7,687,754 | — | plan? |
| Mar 20, 2017 SForm 4 → | Mar 22, 8:39 pm EDT | Anastasios GianakakosPresident and CEO, Director | 1,412 | $15.00 | $21,180 | 508,042 | −0.28% | plan? |
| Mar 20, 2017 MForm 4 → | Mar 22, 8:39 pm EDT | Anastasios GianakakosPresident and CEO, Director | 1,200 | $1.51 | $1,812 | 509,454 | — | plan? |
| Mar 20, 2017 SForm 4 → | Mar 22, 8:37 pm EDT | Jake BauerSee Remarks | 667 | $15.00 | $10,005 | 83,900 | −0.79% | plan? |
| Nov 29, 2016 JForm 4 → | Dec 1, 5:29 pm EST | Third Rock Ventures II, L.P. +410% Owner | 850,000 | — | — | 8,537,754 | — | plan? |
| Nov 29, 2016 JForm 4 → | Dec 1, 5:28 pm EST | Kevin P StarrDirector, 10% Owner | 850,000 | — | — | 8,537,754 | — | plan? |
| Nov 29, 2016 JForm 4 → | Dec 1, 5:25 pm EST | Charles J HomcyDirector | — | — | — | 0 | — | plan? |
| Oct 31, 2016 AForm 4 → | Nov 2, 5:42 pm EDT | Joseph LambingSee Remarks | 1,263 | $10.03 | $12,668 | 123,583 | — | plan? |
| Oct 31, 2016 AForm 4 → | Nov 2, 5:41 pm EDT | Jake BauerSee Remarks | 1,519 | $10.03 | $15,236 | 84,567 | — | plan? |
| Oct 31, 2016 AForm 4 → | Nov 2, 5:40 pm EDT | Anastasios GianakakosPresident and CEO, Director | 898 | $10.03 | $9,007 | 508,254 | — | plan? |
| Oct 3, 2016 PForm 4 → | Oct 5, 9:00 am EDT | Sanofi10% Owner | 450,000 | $15.00 | $6,750,000 | 3,668,899 | +14.0% | plan? |
| Apr 29, 2016 AForm 4/A → | Mar 1, 2017, 9:04 pm EST | Anastasios GianakakosPresident and CEO, Director | 2,279 | $8.50 | $19,372 | 484,444 | — | plan? |
| Apr 29, 2016 PForm 4 → | May 6, 6:24 pm EDT | Anastasios GianakakosPresident and CEO, Director | 2,279 | $8.50 | $19,372 | 484,444 | +0.47% | plan? late amended |
| Apr 29, 2016 AForm 4 → | May 6, 4:51 pm EDT | Jake BauerSee Remarks | 1,416 | $8.50 | $12,036 | 83,048 | — | plan? late |
| Apr 29, 2016 AForm 4 → | May 6, 4:21 pm EDT | Joseph LambingSee Remarks | 1,233 | $8.50 | $10,481 | 122,320 | — | plan? late |
| Apr 29, 2016 AForm 4 → | May 6, 4:20 pm EDT | Jonathan C FoxChief Medical Officer | 1,807 | $8.50 | $15,360 | 240,997 | — | plan? late |
| Nov 3, 2015 PForm 4 → | Nov 5, 8:41 pm EST | Jonathan C FoxChief Medical Officer | 3,000 | $10.00 | $30,000 | 239,190 | +1.27% | plan? |
| Nov 3, 2015 PForm 4 → | Nov 5, 8:38 pm EST | Anastasios GianakakosPresident and CEO, Director | 1,350 | $10.00 | $13,500 | 482,165 | +0.28% | plan? |
| Nov 3, 2015 PForm 4 → | Nov 5, 8:38 pm EST | Mark L PerryDirector | 5,000 | $10.00 | $50,000 | 25,408 | +24.5% | plan? |
| Nov 3, 2015 CForm 4 → | Nov 5, 6:25 pm EST | Third Rock Ventures II, L.P. +710% Owner | 10,340,135 | — | — | 1,496,598 | — | plan? |
| Nov 3, 2015 CForm 4 → | Nov 5, 4:30 pm EST | Kevin P StarrDirector, 10% Owner | 10,340,135 | — | — | 1,496,598 | — | plan? |
| Nov 3, 2015 PForm 4 → | Nov 5, 2:37 pm EST | Sanofi10% Owner | 900,000 | $10.00 | $9,000,000 | 3,218,899 | +38.8% | plan? |
| Nov 3, 2015 CForm 4 → | Nov 5, 2:37 pm EST | Sanofi10% Owner | 2,318,899 | — | — | 2,318,899 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 7, 2016 AForm 4 → | Mar 8, 3:27 pm EST | Sunil AgarwalDirector | 22,000 | — | — | 22,000 | — | |
| Feb 2, 2016 AForm 4 → | Feb 4, 8:22 pm EST | Jake BauerSee Remarks | 34,014 | — | — | 34,014 | — | |
| Feb 2, 2016 AForm 4 → | Feb 4, 8:06 pm EST | Robert Scott McDowellSenior VP, Drug Discovery | 27,211 | — | — | 27,211 | — | |
| Feb 2, 2016 AForm 4 → | Feb 4, 8:06 pm EST | Joseph LambingSee Remarks | 27,211 | — | — | 27,211 | — | |
| Feb 2, 2016 AForm 4 → | Feb 4, 8:05 pm EST | Steven ChanSee Remarks | 23,800 | — | — | 23,800 | — | |
| Feb 2, 2016 AForm 4 → | Feb 4, 8:05 pm EST | Anastasios GianakakosPresident and CEO, Director | 72,562 | — | — | 72,562 | — | |
| Nov 3, 2015 CForm 4 → | Nov 5, 6:25 pm EST | Third Rock Ventures II, L.P. +710% Owner | 38,000,000 | — | — | 0 | — | |
| Nov 3, 2015 CForm 4 → | Nov 5, 4:30 pm EST | Kevin P StarrDirector, 10% Owner | 38,000,000 | — | — | 0 | — | |
| Nov 3, 2015 CForm 4 → | Nov 5, 2:37 pm EST | Sanofi10% Owner | 8,521,955 | — | — | 0 | — | |
| Oct 28, 2015 AForm 4 → | Oct 30, 8:38 pm EDT | Mark L PerryDirector | 21,800 | — | — | 21,800 | — |